WNT5A and idiopathic pulmonary fibrosis: Considering the possible clinical relevance of anti‐fibrotic HBEC EVs for IPF treatment, it is important to show that selected miRNAs in HBEC EVs can directly suppress WNT5A and WNT10B expression.